Possible New Coronavirus Vaccine Made Without Using Cells From Aborted Babies

Vaccine Baby Parts Sales Coronavirus LifeNews Medical Planned Parenthood Press ProLife

Possible New Coronavirus Vaccine Made Without Using Cells From Aborted Babies

A potential coronavirus vaccine being tested in Australia could be the ethical alternative that pro-life advocates have been asking for. So far, the vaccine from Oxford University/AstraZeneca has been considered the most promising for COVID-19, but researchers are using cells from aborted babies in their testing – a huge ethical concern for pro-lifers.

Vaccine Company Sanofi-Pasteur Stops Using Aborted Baby Parts to Make Polio Vaccine

Pro-life advocates’ calls to stop producing vaccines with cells from aborted babies are making a difference in the world. The Catholic News Agency reports the company Sanofi-Pasteur just announced plans to produce a new, ethically-developed polio vaccine. The project will replace an older polio vaccine that was developed with cells from an aborted baby, according to the report.

Possible New Coronavirus Vaccine Made With Cells Taken From Aborted Babies

Prominent bioethics groups are raising concerns about a potential new coronavirus vaccine because British scientists used material from aborted babies to make it. According to Crux Now, the Oxford University research project has many hoping for success after a human trial began last week.

An Ethics Assessment of COVID-19 Vaccine Programs

Vaccine List Table updated last June 19, 2020 This is Issue 46 in CLI’s On Point Series. To view this report as a PDF, see: On Point 46: An Ethics Assessment of COVID-19 Vaccine Programs The recent global concern for a devastating disease impact by COVID-19, the disease caused by the newly identified SARS-CoV-2 (CoV-19) coronavirus, has prompted a rapid intensification of efforts to develop an effective vaccine to limit the spread of the virus and to reduce COVID-19 illness and deaths.

Trump Admin Funding Pro-Life Alternatives to Using Aborted Baby Parts for Research

The Trump administration issued a plan Monday to promote ethical alternatives to aborted baby body parts in scientific research. The grants, under the National Institute of Health, will provide $20 million to develop alternatives to “human fetal tissue obtained from elective abortions,” according to the notice published Monday by the U.S.